Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)
Department of Health and Human Services
Through this Notice of Funding Opportunity (NOFO), entitled "Toward Translation of Nanotechnology Cancer Interventions" (TTNCI), the National Cancer Institute (NCI) encourages applications for advanced pre-clinical research, supporting translation of nanotechnology-based cancer diagnostics and therapeutics. TTNCI awards are designed to mature experimental nanomedicines relying on nanoparticles and nano-devices which demonstrate strong potential to improve cancer treatment effectiveness due to the combination of nanoparticle/nano-device structural design and/or therapeutic/diagnostic cargo which is delivered. TTNCI awards are expected to enable further development of proposed nanotechnology-b
Funding
Award size
Not specified
Type
Grant
Dates
Deadline
Later
Posted
12/16/2024
Closes
2027-11-15
Eligibility
Eligibility
County governmentsCity or township governmentsPrivate institutions of higher educationFor profit organizations other than small businessesNonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationPublic and State controlled institutions of higher educationIndependent school districtsState governmentsPublic housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Others (see text field entitled "Additional Information on Eligibility" for clarification)Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationNative American tribal governments (Federally recognized)Special district governmentsSmall businesses
Program
Funding area
Education - EDHealth - HL
Opportunity #
PAR-25-336
Source
Status
Open
Market
Government
Level
Federal
Source
Grants.gov